Specifically, a one‐unit increase in the value of biomarker F2 would result in an increase of the odds ratio (delirium vs. non‐delirium) by a factor of exp(0.562) = 1.75, a one‐unit increase in the value of biomarker ADAM10 would result in an increase in the odds ratio (delirium vs. non‐delirium) by a factor of exp(0.534) = 1.71, and a one‐unit increase in the value of biomarker CTSB would result in an increase in the odds ratio (delirium vs. non‐delirium) by a factor of exp(0.121) = 1.13. The gene discussed is ADAM10; the disease is delirium.